---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-26-002900"
form_type: "8-K"
ticker: "SLXN"
cik: "0002022416"
company_name: "Silexion Therapeutics Corp"
filed_at: "2026-05-26T12:48:49+00:00"
generated_at: "2026-05-26T12:50:27.315562+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Silexion Therapeutics announces 1-for-10 reverse share split to maintain Nasdaq listing

## Summary
- Reverse share split at 1:10 ratio; effective after market close May 28, 2026; split-adjusted trading begins May 29, 2026.
- Ticker remains SLXN; new CUSIP assigned; par value increases from $0.0135 to $0.135 per share.
- No fractional shares issued; DTC participants' fractional shares rounded up to nearest whole share.
- Split intended to maintain Nasdaq minimum bid price compliance (Rule 5550(a)(2)) and support equity financings.

## SEC filing metadata
- accession: 0001178913-26-002900
- form_type: 8-K
- ticker: SLXN
- cik: 0002022416
- company_name: Silexion Therapeutics Corp
- filed_at: 2026-05-26T12:48:49+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2022416/000117891326002900/0001178913-26-002900-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2022416/000117891326002900/zk2635400.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-26-002900
- JSON: https://secwatch.observer/filing/0001178913-26-002900.json
- Plain text: https://secwatch.observer/filing/0001178913-26-002900.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.